Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.
Liontos M, Trigka EA, Korkolopoulou P, Tzannis K, Lainakis G, Koutsoukos K, Kostouros E, Lykka M, Papandreou CN, Karavasilis V, Christodoulou C, Papatsoris A, Skolarikos A, Varkarakis I, Adamakis I, Alamanis C, Stravodimos K, Mitropoulos D, Deliveliotis C, Constantinidis CA, Saetta A, Patsouris E, Dimopoulos MΑ, Bamias A. Liontos M, et al. Among authors: alamanis c. World J Urol. 2017 Mar;35(3):411-419. doi: 10.1007/s00345-016-1890-7. Epub 2016 Jul 9. World J Urol. 2017. PMID: 27395374
Pain during transrectal ultrasonography guided prostate biopsy: a randomized prospective trial comparing periprostatic infiltration with lidocaine with the intrarectal instillation of lidocaine-prilocain cream.
Adamakis I, Mitropoulos D, Haritopoulos K, Alamanis C, Stravodimos K, Giannopoulos A. Adamakis I, et al. Among authors: alamanis c. World J Urol. 2004 Oct;22(4):281-4. doi: 10.1007/s00345-003-0386-4. Epub 2003 Dec 20. World J Urol. 2004. PMID: 14689224 Clinical Trial.
Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.
Bamias A, Bozas G, Antoniou N, Poulias I, Katsifotis H, Skolarikos A, Mitropoulos D, Alamanis C, Alivizatos G, Deliveliotis H, Dimopoulos MA. Bamias A, et al. Among authors: alamanis c. Eur Urol. 2008 Feb;53(2):323-31. doi: 10.1016/j.eururo.2007.03.072. Epub 2007 Apr 5. Eur Urol. 2008. PMID: 17445976
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer.
Mountzios I, Bournakis E, Efstathiou E, Varkaris A, Wen S, Chrisofos M, Deliveliotis C, Alamanis C, Anastasiou I, Constantinides C, Karadimou A, Tsiatas M, Papadimitriou C, Bamias A, Dimopoulos MA. Mountzios I, et al. Among authors: alamanis c. Urology. 2011 Mar;77(3):682-7. doi: 10.1016/j.urology.2010.08.044. Epub 2011 Jan 22. Urology. 2011. PMID: 21256546
Implementation and external validation of Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) score for predicting complications in 74 consecutive partial nephrectomies.
Tyritzis SI, Papadoukakis S, Katafigiotis I, Adamakis I, Anastasiou I, Stravodimos KG, Alamanis C, Mitropoulos D, Constantinides CA. Tyritzis SI, et al. Among authors: alamanis c. BJU Int. 2012 Jun;109(12):1813-8. doi: 10.1111/j.1464-410X.2011.10644.x. Epub 2011 Oct 7. BJU Int. 2012. PMID: 21981696
35 results